• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM
Click for more information
0.00% 2.9¢

CHIMERIC THERAPEUTICS LIMITED - Charts / Financials

Market Cap $24.70M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase I clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of four NK and CAR NK assets with plans for Phase I clinical trials in solid tumors and blood cancers.More

refresh Created with Sketch. REFRESH
Last update - 15.44pm 03/05/2024 (20 minute delay) ?
Day
Open 2.9¢   Day High 2.9¢   Day Low 2.8¢
Daily Volume 913859
Bids   Sellers
Number Price Volume   Number Price Volume
6 2.7¢ 5503899   4 3.0¢ 301388

Directors & Senior Management

Mr. Paul Hopper Executive Chairman of the Board, Founder
Ms. Jennifer Know Chow Chief Executive Officer, Managing Director, Executive Director
Mr. Phillip Hains Chief Financial Officer, Joint Company Secretary, Director
Dr. Eliot Bourk Chief Business Officer
Dr. Jason B. Litten Chief Medical Officer
Mr. Nathan Jong Joint Company Secretary
Dr. Lesley Russell Non-Executive Director
Mr. Eric M. Sullivan Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
2.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $24.70M
Open High Low Value Volume
2.9¢ 2.9¢ 2.8¢ $25.82K 913.8K

Buyers (Bids)

No. Vol. Price($)
6 5503899 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 301388 4
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
2.9¢ 		  Change
0.000 ( 3.57 %)
Open High Low Volume
2.8¢ 2.9¢ 2.7¢ 743366
Last updated 15.44pm 03/05/2024 ?

Top Stories

Macquarie profits fall 32% on 'market volatility' and low-achieving 'green investments'

Macquarie Bank has shaved more than 30 percent off its net profit in the final quarter of the 2024 financial year (FY 2024), compared to the same time last year, with executives speaking cautiously about market volatility and @lower asset realisations’ from green investments, but ...
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Dancing to that same 70s tune, China, and why I'm backing gold It is too early to judge what concrete measures the Future Made in Australia policy will entail. However, any policy which has a stated aim to screen qualifying capital for suitability at a government level, does not seem like a strong signal for foreigners to get on a plane, come visit some mine sites and invest.
Patagonia shares rise above 20% on lithium grades at maiden well in Argentina Patagonia Lithium shares rise above 12 percent on lithium grading nearly 600 parts per million at the first drill well of its Argentinian Formentera Lithium Project.
Carnarvon revs up for revised Dorado Development The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.